在加利福尼亚州利用基于人群的SARS-CoV-2调查定义长新冠
加州公共卫生部开展横断面调查,随机选取加州家庭,分析2883名既往SARS-CoV-2检测阳性者。采用五种长新冠定义评估患病率,最高为恢复不完全(20.9%,95%CI 19.4-22.5),最低为严重影响的长新冠(4.9%,95%CI 4.1-5.7)。完成基础疫苗接种系列者长新冠患病率显著低于未接种者。
要点
- 不同长新冠定义下患病率差异显著,最高20.9%,最低4.9%。
- 完成基础疫苗接种系列者长新冠患病率显著低于未接种者。
- 初始COVID-19感染严重者应考虑长新冠概率更高。
核心结论
- 不同定义下长新冠估计患病率存在显著差异。
- 初始COVID-19感染严重者应考虑长新冠概率更高。
- 完成基础疫苗接种系列者长新冠患病率显著低于未接种者。
研究设计与样本
- 加州公共卫生部(CDPH)开展的横断面调查,随机选取加州家庭参与。
- 调查内容包括人口学信息、临床症状和COVID-19疫苗接种史。
- 分析纳入2883名既往SARS-CoV-2检测阳性参与者,采用logistic回归评估不同定义下长新冠患病率及预测因素。
主要发现
- 参与者中女性占62.5%,中位年龄39岁(四分位距17-55岁)。
- 恢复不完全定义下长新冠患病率最高,为20.9%(95%CI 19.4-22.5)。
- 严重影响的长新冠患病率最低,为4.9%(95%CI 4.1-5.7)。
- 完成基础疫苗接种系列者长新冠患病率显著低于未接种COVID疫苗者。
关键数值与推荐
- 不同定义下长新冠患病率存在显著差异,最高为恢复不完全20.9%(95%CI 19.4-22.5),最低为严重影响的长新冠4.9%(95%CI 4.1-5.7)。
- 完成基础疫苗接种系列者长新冠患病率显著低于未接种者。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: More than four years after the start of the COVID-19 pandemic, understanding of SARS-CoV-2 burden and post-acute sequela of COVID (PASC), or long COVID, continues to evolve. However, prevalence estimates are disparate and uncertain. Leveraging survey responses from a large serosurveillance study, we assess prevalence estimates using five different long COVID definitions among California residents. METHODS: The California Department of Public Health (CDPH) conducted a cross-sectional survey that included questions about acute COVID-19 infection and recovery. A random selection of California households was invited to participate in a survey that included demographic information, clinical symptoms, and COVID-19 vaccination history. We assessed prevalence and predictors of long COVID among those previously testing positive for SARS-CoV-2 across different definitions using logistic regression. FINDINGS: A total of 2883 participants were included in this analysis; the majority identified as female (62.5 %), and the median age was 39 years (interquartile range: 17-55 years). We found a significant difference in long COVID prevalence across definitions with the highest prevalence observed when participants were asked about incomplete recovery (20.9 %, 95 % confidence interval [CI]: 19.4-22.5) and the lowest prevalence was associated with severe long COVID affecting an estimated 4.9 % (95 % CI 4.1-5.7) of the participant population. Individuals that completed the primary vaccination series had significantly lower prevalence of long COVID compared to those that did not receive COVID vaccination. INTERPRETATION: There were significant differences in the estimated prevalence of long COVID across different definitions. People who experience a severe initial COVID-19 infection should be considered at a higher probability for developing long COVID. FUNDING: Centers for Disease Control and Prevention - Epidemiology and Laboratory Capacity.
引用
- Pry JM, McCullough K, Lai KW, et al. Defining long COVID using a population-based SARS-CoV-2 survey in California. Vaccine. 2024. PMID: 39293298. doi:10.1016/j.vaccine.2024.126358
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。